Delivery Order W81K0018D0010-W81K0019F0361
Award Date 10/1/19
Potential Completion Date 9/30/20
Potential Value $2.9M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,280,000 firm-fixed-price contract is for histology testing services at the Brooke Army Medical Center in JBSA Fort Sam Houston, Texas for Fiscal Year 2020. The contract has no set-aside designation. Roche Diagnostics has a history of providing critical...
- The Defense Health Agency awarded a $397,692.13 delivery order to Roche Diagnostics Corporation for continued chemistry and immunoassay testing services on a cost-per-reportable-result (CPRR) basis. This child delivery order, designated as W81K0024F0153, is scheduled for completion by April 4, 2026, and will be performed at Fort Sam Houston in San Antonio, Texas. The contract employs firm fixed-price pricing without set-aside designation, reflecting open competition. Roche Diagnostics...
- The Department of the Army Medical Command awarded a firm fixed-price delivery order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $1,280,000.00 contract is for histology cost-per-test services to be provided to the Brooke Army Medical Center, with a completion date of September 30, 2018. Roche Diagnostics has provided similar medical equipment and supplies to various federal agencies through...
- The Department of the Army Medical Command awarded a $177,482.40 firm fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of test reagents and has a completion date of September 30, 2022. Roche has previously received other federal contract awards, including Indefinite Delivery Contracts and Blanket Purchase Agreements, to supply a range of medical...
- The Defense Health Agency has awarded a delivery order valued at $2.19M to Roche Diagnostics Corporation for core laboratory chemistry testing services through September 30, 2025. This firm fixed-price delivery order, which was awarded on October 1, 2024, will be performed at Fort Sam Houston in San Antonio, Texas, supporting the military healthcare system's diagnostic testing capabilities. The award carries no set-aside designation, indicating it was competed openly in the federal...
- This federal contract award was made by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $887,473.92 firm fixed-price delivery order was placed against Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). It does not have a set-aside...
- The Defense Health Agency awarded a $6.1 million firm fixed-price purchase order to Roche Diagnostics Corporation on October 1, 2021, for advanced histology staining services including immunohistochemistry, in-situ hybridization, and immunofluorescence testing. The contract supports Brooke Army Medical Center at Joint Base San Antonio Fort Sam Houston in Texas and operates on a cost-per-test model with an ultimate completion date of September 30, 2026. No set-aside designation was used in this...
- Roche Diagnostics Corporation received a $200,000 delivery order from the Defense Health Agency for chemistry cost-per-reportable-result testing services, with a completion date of June 30, 2024. The award was issued on December 31, 2023, without a set-aside designation under open competition. This delivery order is a child contract stemming from Roche's established General Services Administration Schedule contract under the Critical Analyzers, Laboratory (FSS-66-III) schedule, which enables the...
- Roche Diagnostics Corporation was awarded a $2.38 million firm fixed-price purchase order by the Defense Health Agency on September 1, 2025, to supply chemistry immunoassay testing reagent kits and analyzer equipment to the William Beaumont Army Medical Center at Fort Bliss, Texas. The contract, which runs through September 30, 2027, originated from a competitive solicitation (W81K00-25-Q-A091) evaluated using a Lowest Price Technically Acceptable process. Under this cost-per-kit arrangement,...
- This firm fixed price purchase order was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation for $3,934,000 to supply molecular diagnostics equipment. The place of performance is in San Antonio, Texas and the period of performance concludes on September 30, 2023. No set-aside designation was used for this procurement. Roche Diagnostics will provide the equipment under their designation as a manufacturer of medical goods. This award draws from Roche's experience...